Blog
You Don’t Need RIMS: Other Options Are Sufficient
For medium-sized organizations, a well-designed Regulatory Data Layer (RDL) (or some companies call as Regulatory master data) can potentially provide the capabilities that matter most from a regulatory perspective without requiring a large, monolithic enterprise RIMS implementation.
The key distinction is: you still need regulatory data and information management; you may not need a traditional RIMS as the primary application.
Why a Regulatory Data Layer can be enough?
Medium-sized companies have a smaller regulatory footprint
A large pharma company may have thousands of products, hundreds of markets, complex legal-entity structures, and enormous submission volumes.
A medium-sized organization may have Fewer products, Fewer markets, Smaller regulatory teams, Lower submission volumes, less complex organizational structures
In that environment, implementing a full enterprise RIMS can introduce substantial configuration, administration, integration, licensing, and change-management overhead.
An RDL can provide the common regulatory information foundation without necessarily replacing every existing application.
The real problem is often fragmented data – not lack of another application
Imagine regulatory information already exists across:
- Document management
- Quality systems
- Submission publishing
- SharePoint
- Spreadsheets
Buying another large application does not automatically solve fragmentation.
Instead, an RDL can sit across these systems:
Source systems → Regulatory Data Layer → AI / Analytics / Applications
This type of approach provides a consistent representation of:
Product → Country → Authorization → Submission → Sequence → Commitment → Regulatory Event → Document
The systems remain where they are, while the RDL provides the common regulatory context.
You can avoid duplicating the systems of record
A well-designed RDL shouldn’t become another giant database where every regulatory data or document and record is copied.
Instead, it can maintain Regulatory master data, Key metadata, Relationships, References to source records, Regulatory events, Status, and Access controls
For example:
| Regulatory question | RDL role |
| What products do we have? | Product reference/master data |
| Where are they authorized? | Authorization relationships |
| What submissions exist? | Submission metadata |
| What documents support them? | Document references |
| What commitments remain? | Commitment data |
| Where did this information come from? | Provenance |
| What changed? | Events/history |
| Who can access it? | Governance/access layer |
This is important because the RDL becomes a layer of intelligence and context rather than another repository competing with existing systems or increasing maintenance/support costs
For a medium-sized pharma company, the question may no longer be “Which RIMS should we buy?” but “What regulatory capabilities do we actually need, and can a governed regulatory data layer connect our existing systems and AI agents to deliver them?”
The critical word is governed. Without data ownership, provenance, access control, auditability, lifecycle management, and appropriate controls around AI actions, an RDL can simply become another integration layer rather than a credible regulatory foundation.
Get the latest updates from DDi
Explore Topics
- Automation & AI (31)
- Clinical Automation (8)
- Consumer Health (1)
- IRT & Clinical Supplies (28)
- Labeling (18)
- Regulations (34)
- Regulatory Automation (14)
- Regulatory Biopharma (4)
- Regulatory Content Management (4)
- Regulatory Information Management (25)
- UDI (46)
- Writing (26)
Recent Blogs
You Don’t Need RIMS: Othe…In Regulatory Information Management
UDI Packaging Data Challe…In UDI
Different QC options. Why…In Automation & AI
Previous Post
Next Post
Related Posts
CONNECT WITH US
Let's talk about how DDi can help you